Biological Magnetic Resonance Data BankA Repository for Data from NMR Spectroscopy on Proteins, Peptides, Nucleic Acids, and other Biomolecules |
Member of |
Entry ID | Data summary | Entry Title | Citation Title | Authors |
---|---|---|---|---|
31102 | Chemical Shifts: 1 set |
NMR structure of L5pG ([p23W, G24W]kalata B1) | Nucleation of a key beta-turn promotes cyclotide oxidative folding | Conan K Wang, David J Craik, Simon J de Veer, Sixin Tian, Thomas Durek |
30938 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
hyen D solution structure | Mutagenesis of bracelet cyclotide hyen D reveals functionally and structurally critical residues for membrane binding and cytotoxicity | Conan K Wang, David J Craik, Qingdan Du, Quentin Kaas, Yen-Hua H Huang |
50567 | Chemical Shifts: 1 set |
Structure of PCSK9 antagonist P9-38 | Bioactive cyclization optimizes the affinity of a proprotein convertase subtilisin/kexin type 9 (PCSK9) peptide inhibitor | Benjamin J Tombling, Carmen Lammi, Conan K Wang, David J Craik, Edward K Gilding, Giovanni Grazioso, Nicole Lawrence |
50316 | Chemical Shifts: 1 set |
ABD12 | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50319 | Chemical Shifts: 1 set |
ABD2 | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50318 | Chemical Shifts: 1 set |
ABD1 | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50323 | Chemical Shifts: 1 set |
ABD23ac | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50322 | Chemical Shifts: 1 set |
ABD23ss | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50320 | Chemical Shifts: 1 set |
ABD3 | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50321 | Chemical Shifts: 1 set |
ABD2' | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50317 | Chemical Shifts: 1 set |
ABD23 | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
50315 | Chemical Shifts: 1 set |
ABD | Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery | Anna A Amiss, Conan K Wang, David J Craik, Joachim Weidmann |
30671 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
NMR solution structure of triazole bridged plasmin inhibitor | Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides | Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek |
30666 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
NMR solution structure of SFTI-R10 | Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides | Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek |
30667 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
NMR solution structure of SFTI1 based KLK7 protease inhibitor | Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides | Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek |
30668 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
NMR solution structure of SFTI-1 based plasmin inhibitor | Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides | Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek |
30669 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
NMR solution structure of triazole bridged matriptase inhibitor | Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides | Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek |
30670 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
NMR solution structure of a triazole bridged KLK7 inhibitor | Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides | Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek |
30654 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
NMR solution structure of triazole bridged SFTI-1 | Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides | Andrew White, Conan K Wang, David Craik, Gordon J King, Guojie Wu, Joakim E Swedberg, Kuok Yap, Peta Harvey, Ruby Law, Simon de Veer, Thomas Durek |
25152 | Chemical Shifts: 1 set |
Solution structure MTAbl13, a grafted MCoTI-II | Design of substrate-based BCR-ABL kinase inhibitors using the cyclotide scaffold | Conan Wang, David Craik, Louise Thorstholm, Norelle Daly, Quentin Kaas, Sonia Henriques, Yen-Hua Huang |
19874 | Chemical Shifts: 1 set |
Solution Structure of kalata B1[W23WW] | Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting | Conan Wang, David Craik, Sonia Troeira Henriques, Stephanie Chaousis, Yen-Hua Huang |
19177 | Chemical Shifts: 1 set |
[Asp2,11]RTD-1 | The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif | Alexander Bochen, Anne C Conibear, Conan Wang, David J Craik, Horst Kessler, K Johan Rosengren, Petar Stupar |
19176 | Chemical Shifts: 1 set |
[Asp11]RTD-1 | The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif | Alexander Bochen, Anne C Conibear, Conan Wang, David J Craik, Horst Kessler, K Johan Rosengren, Petar Stupar |
19175 | Chemical Shifts: 1 set |
[Asp2]RTD-1 | The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif | Alexander Bochen, Anne C Conibear, Conan Wang, David J Craik, Horst Kessler, K Johan Rosengren, Petar Stupar |
16074 | Chemical Shifts: 1 set |
Solution structure of micelle-bound kalata B2 | Despite a conserved cystine knot motif, different cyclotides have different membrane binding modes | Conan K Wang, David C Ireland, David J Craik, Michelle L Colgrave, Quentin Kaas |
16073 | Chemical Shifts: 1 set |
Solution structure of cycloviolacin O2 | Despite a conserved cystine knot motif, different cyclotides have different membrane binding modes | Conan K Wang, David C Ireland, David J Craik, Michelle L Colgrave, Quentin Kaas |